Masayuki Miyasaka Selected Research

Bleomycin (Blenoxane)

1/2017

Amine oxidase activity regulates the development of pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Miyasaka Research Topics

Disease

18	Neoplasms (Cancer) 04/2022 - 08/2002
9	Inflammation (Inflammations) 01/2019 - 04/2002
6	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2002
3	Rheumatoid Arthritis 10/2014 - 01/2002
2	Fibrosis (Cirrhosis) 01/2017 - 01/2012
2	Infections 08/2014 - 10/2006
2	Arthritis (Polyarthritis) 08/2013 - 01/2010
2	Ureteral Obstruction 01/2004 - 04/2003
1	Breast Neoplasms (Breast Cancer) 04/2022
1	Lymphatic Metastasis 04/2022
1	Vasculitis (Vasculitides) 01/2019
1	Colonic Neoplasms (Colon Cancer) 11/2018
1	Pathologic Processes 01/2017
1	Eosinophilia 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Osteoarthritis 10/2014
1	Experimental Arthritis 10/2014
1	Peritonitis 08/2014
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2012
1	Hepatitis C 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Fatty Liver 01/2012
1	Chronic Hepatitis C 01/2012
1	Crohn Disease (Crohn's Disease) 02/2011
1	Colitis 02/2011
1	Thymoma (Thymic Carcinoma) 02/2010
1	Atrophy 09/2009
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Wounds and Injuries (Trauma) 09/2008
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2008
1	Catalepsy 11/2007
1	Atherosclerosis 02/2007
1	Lymphadenopathy 07/2003

Drug/Important Bio-Agent (IBA)

9	ChemokinesIBA 04/2022 - 04/2003
6	CytokinesIBA 04/2022 - 01/2002
6	Hyaluronic Acid (Hyaluronan)IBA 05/2010 - 11/2002
6	OligosaccharidesIBA 01/2010 - 11/2002
5	L-SelectinIBA 12/2008 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
4	Monoclonal AntibodiesIBA 11/2018 - 11/2002
3	LigandsIBA 04/2022 - 11/2002
3	LipidsIBA 01/2019 - 08/2002
3	lysophosphatidic acidIBA 01/2019 - 08/2013
3	Lysophosphatidic Acid ReceptorsIBA 01/2019 - 08/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 09/2002
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010 - 09/2002
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2009 - 08/2002
2	Collagen Type II (Type II Collagen)IBA 08/2013 - 01/2010
2	Therapeutic UsesIBA 01/2012 - 11/2002
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2011 - 09/2002
2	Biological ProductsIBA 02/2011 - 03/2006
2	P-SelectinIBA 09/2008 - 11/2002
2	SelectinsIBA 04/2003 - 11/2002
1	Rituximab (Mabthera)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2020
1	Chemotactic FactorsIBA 01/2019
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2018
1	AntibodiesIBA 12/2017
1	AminesIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	CollagenIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	Messenger RNA (mRNA)IBA 10/2014
1	Integrin alpha4beta1 (VLA-4)IBA 08/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2013
1	GlycogenIBA 01/2012
1	InterleukinsIBA 01/2012
1	Poly CIBA 01/2012
1	AcidsIBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Etanercept (Enbrel)FDA Link 02/2011
1	Interleukin-17 (Interleukin 17)IBA 02/2011
1	InterferonsIBA 02/2011
1	PaxillinIBA 02/2010
1	chondroitin sulfate E hexasaccharideIBA 01/2010
1	Interleukin-15 (Interleukin 15)IBA 09/2009
1	Glutens (Glutelin)IBA 09/2009
1	Heparitin Sulfate (Heparan Sulfate)IBA 07/2009
1	Dermatan SulfateIBA 07/2009
1	P-selectin ligand proteinIBA 12/2008
1	Cell Adhesion MoleculesIBA 05/2008
1	RacloprideIBA 11/2007
1	Cocaine (Cocaine HCl)IBA 11/2007
1	SK&F 81297IBA 11/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2007
1	NF-kappa B (NF-kB)IBA 02/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2007
1	PolymersIBA 03/2006
1	Tissue Inhibitor of Metalloproteinase-2IBA 02/2004
1	Metalloproteases (Metalloproteinases)IBA 02/2004
1	KB R7785IBA 02/2004
1	galactosylceramide sulfotransferaseIBA 01/2004
1	AntigensIBA 07/2003
1	Collagen Type XVIII (Type XVIII Collagen)IBA 04/2003

Therapy/Procedure

5	Therapeutics 01/2019 - 11/2002
4	Immunotherapy 01/2022 - 11/2010
1	Ligation 08/2014
1	Punctures 08/2014